American actress Christina Applegate is exploring another possible explanation for her ongoing health struggles, suggesting that her breast implants could be a contributing factor. The 52-year-old actress raised the concern during a recent episode of her 'MeSsy' podcast with co-host Jamie-Lynn Sigler.
Applegate, who underwent a double mastectomy in 2008 following a breast cancer diagnosis, stated she believes her implants are due for replacement. This possibility emerged after she reviewed a study suggesting that symptoms associated with breast implants can mimic those of multiple sclerosis (MS).
Applegate was initially diagnosed with MS in 2021, though medical professionals later determined the diagnosis was incorrect. She intends to discuss the implant issue with her medical team to determine if there is a correlation between the hardware and her current physical decline.
Meanwhile, her physical mobility has significantly declined; she described severe joint pain and an inability to move her right shoulder. "I don't know what's going on in my joints, but I can't move my right shoulder at all now.
I can't lift my arm," she remarked, adding that the pain makes even sitting up in bed a 10-minute ordeal. The actress has been vocal about the toll these health issues have taken on her daily life.
She noted that the unpredictability of her symptoms makes planning for the future difficult, as she often struggles with basic tasks that were previously effortless. Medical experts are currently investigating several conditions that present with symptoms similar to MS, including rheumatoid arthritis, lupus, and Lyme disease.
These diagnostic challenges have left the actress searching for answers. Applegate's transparency regarding her health journey has resonated with many fans, sparking broader conversations about the long-term effects of medical implants and the complexities of autoimmune-like symptoms.
As she continues to work with her doctors, the actress remains focused on finding a definitive diagnosis. Her podcast serves as a platform for her to process these challenges while connecting with others facing similar health uncertainties.
The medical community continues to monitor cases where implant-related illness is suspected, though it remains a subject of ongoing research. For now, Applegate is prioritizing her recovery and seeking clarity on her path forward.
The public and her supporters await further updates as she navigates this difficult chapter, hoping for a resolution that will alleviate her chronic pain and restore her quality of life.
